Long COVID Therapeutics and Care Models: Navigating Ethics, Policy, and Patient Realities

Long COVID Therapeutics and Care Models: Navigating Ethics, Policy, and Patient Realities

A single persistent cough can declare a battle that medical science is only beginning to understand. With millions still grappling with post-acute sequelae of SARS-CoV-2 infection—known as long COVID—clinical trials of antivirals and immunomodulators are offering glimmers of relief just as healthcare systems race to establish comprehensive care models. Unveiling Antiviral Promise and Uncertainty Nirmatrelvir-ritonavir, better known by its brand …